Free Download — No Credit Card Required

Labeling & Storage of Drugs

F-761 §483.45(g)(1)–(2) labeling and storage of drugs and biologicals — complete label standard, locked compartment storage, ambient and refrigerated temperature monitoring, controlled substance perpetual inventory, emergency kit inspection, medication destruction log, key access roster, and pre-survey walk-through.

Template Details

F-Tag: F-761 Category: pharmacy Pages: 9 Last reviewed: 2026-07-25
Audience: DON Unit Nurse Manager Consultant Pharmacist Medication Room Staff

Labeling & Storage of Drugs

A complete F-761 §483.45(g)(1)–(2) labeling and storage of drugs and biologicals policy plus survey-ready documentation tools for skilled nursing facilities. This template covers the labeling requirements for prescription medications, over-the-counter medications, biologicals, and compounded preparations stored at the facility, the storage conditions that preserve medication integrity, the controlled substance storage and accountability chain, the emergency medication and contingency stock protocol, the medication destruction protocol for discontinued or expired medications, and the surveyor-encounter workflow CMS uses during F-761 investigations.

F-761 is the F-tag surveyors cite when medications in the facility's possession are not properly labeled, not properly stored, not properly accounted for, or not properly destroyed. Under §483.45(g)(1), the facility must label drugs and biologicals in accordance with currently accepted professional principles and include the appropriate accessory and cautionary instructions as well as the expiration date when applicable. Under §483.45(g)(2), the facility must store all drugs and biologicals in locked compartments under proper temperature controls and permit only authorized personnel to have access to the keys. Surveyors test every medication storage location — medication carts on every unit, central medication rooms, treatment carts, refrigeration units, controlled substance storage, emergency kits, and any backup stock — during the F-761 walkthrough.

The most common citation patterns surveyors document include: medications stored without a complete label (missing expiration date, missing accessory instructions, illegible label from a worn or torn original), expired medications retained in active storage, medications stored outside the required temperature range without documentation of the excursion and corrective action, controlled substances with reconciliation gaps between the perpetual inventory and the actual count, emergency kits not inspected on the facility-defined schedule, discontinued medications retained in active storage awaiting destruction, and unauthorized personnel with access to medication keys or storage areas. This template gives the DON, the unit nurse managers, the consultant pharmacist, and the medication room support staff a single shared paper trail so that every medication in the facility is properly labeled, properly stored, properly accounted for, and properly destroyed.

CMS guidance (State Operations Manual Appendix PP, F-761) treats medication storage as a continuous obligation, not a single inspection event. A properly labeled medication stored in an improper temperature range for any portion of the storage period is treated as a labeling AND storage failure. A controlled substance whose perpetual inventory cannot be reconciled to the actual count at the moment of surveyor inspection is treated as a storage failure regardless of when the discrepancy was introduced. Surveyors pull the medication cart, the central medication room, the treatment rooms, the emergency kits, the refrigerator logs, the perpetual controlled substance inventory, the medication destruction log, and the access roster during the F-761 walkthrough. Surveyors also observe medication pass on at least one unit to confirm that medication access is properly controlled in real time.

This template is intended for use by the Director of Nursing, the unit nurse managers, the licensed nurses administering medications, the medication room support staff, the consultant pharmacist, and the facility's contracted pharmacy vendor. The DON retains facility accountability for the storage program; the consultant pharmacist retains professional accountability for labeling quality and for storage conditions that affect medication integrity; the licensed nurse retains accountability for maintaining storage integrity during the medication pass cycle; and the unit nurse manager retains accountability for the daily and weekly reconciliation routines. The included surveyor walkthrough sheet shall be walked at minimum 30 days before any anticipated survey window.

Purpose

The purpose of this policy is to establish a single, defensible, surveyor-reviewable workflow for medication labeling, storage, controlled substance accountability, emergency kit integrity, and medication destruction under 42 CFR §483.45(g)(1)–(2). It defines the labeling standard for every medication in facility possession, the storage conditions for ambient and refrigerated medications, the temperature monitoring routine, the controlled substance reconciliation cycle, the emergency kit inspection cycle, the destruction protocol for discontinued and expired medications, and the access-control processes required at every level of medication handling.

Policy

The facility shall label and store all drugs and biologicals in accordance with 42 CFR §483.45(g)(1)–(2) and currently accepted professional principles. Every medication in facility possession shall bear a complete and legible label including resident identifier (or "for facility stock" designation, where applicable), medication name, strength, dose, route, frequency, expiration date, and any accessory or cautionary instructions. All medications shall be stored in locked compartments under proper temperature controls, with access limited to authorized personnel. Controlled substances shall be stored in separately locked, permanently affixed compartments with a documented perpetual inventory reconciled against actual count at defined intervals. Emergency medications and contingency stock shall be inspected on facility-defined cycles and shall be sealed with documented access logs. Discontinued or expired medications shall be removed from active storage and destroyed per facility protocol with documented chain-of-custody records.

Scope

This policy applies to every medication and biological in facility possession, including prescription medications, over-the-counter medications, dietary supplements used as medications, compounded preparations, controlled substances, emergency medications, contingency stock, samples, and any resident-owned medications being administered to or stored for the resident. It applies to the Director of Nursing, all licensed nurses administering medications, the unit nurse managers, the medication room support staff, the consultant pharmacist, the contracted pharmacy vendor, and any staff with authorized access to medication keys or storage areas. It applies during routine operations, during medication pass on every unit, during all hours including nights and weekends, during emergency situations, and during any documented vendor change or storage change that affects medication inventory.

Procedure

Labeling standard

Every medication in facility possession shall bear a label that includes, at minimum: the medication name (generic or brand), the strength, the dose, the route of administration, the frequency, the resident identifier (or "for facility stock" designation), the prescribing physician or qualified practitioner (when applicable), the original fill date, the expiration date, the lot or batch identifier (when available), and any accessory or cautionary instructions (shake well, refrigerate, protect from light, take with food). Labels shall be legible; a worn, faded, partially obscured, or otherwise illegible label constitutes a labeling failure even when the underlying information can be reconstructed verbally by staff. Labels shall be replaced immediately when they are damaged or become illegible.

Medication storage areas

The facility shall maintain clearly defined medication storage areas on every unit and in central medication rooms. Each storage area shall be kept locked when unattended. Each storage area shall hold only medications in active service for the residents assigned to that area or facility stock medications. Discontinued medications awaiting destruction shall be segregated from active storage in a labeled "pending destruction" compartment. Medications that are no longer in active service for any resident shall be removed from active storage within facility-defined turnaround (commonly 24 hours after discontinuation).

Temperature monitoring

Refrigerated medications shall be stored between 2°C and 8°C (36°F and 46°F) and shall be monitored continuously with a calibrated thermometer that records minimum and maximum temperatures. Ambient medication storage shall be maintained between 20°C and 25°C (68°F and 77°F) unless a specific medication requires otherwise, with excursions outside the controlled room temperature range documented and addressed. Temperature logs shall be reviewed daily by the unit nurse manager or designee. Any temperature excursion outside the labeled storage range shall trigger a documented review with the consultant pharmacist and any required action for the affected medications.

Controlled substance accountability

Every controlled substance in facility possession shall be tracked on a perpetual inventory log that records the medication, strength, resident assignment, quantity received, quantity administered, quantity wasted, quantity remaining, and two-staff signatures at each transaction. The perpetual inventory shall be reconciled against the actual count at facility-defined intervals (commonly every shift change or at minimum every 24 hours). Any reconciliation discrepancy shall be investigated immediately, documented with the findings, and reported per facility protocol. Discrepancies that cannot be reconciled through documentation review shall be reported through the facility's occurrence reporting mechanism and to the appropriate regulatory authority where required.

Emergency medications and contingency stock

Emergency kits (stat boxes, anaphylaxis kits, narcan kits, etc.) and contingency stock shall be sealed with tamper-evident seals and shall be inspected on facility-defined cycles (commonly every shift or at minimum daily). Each inspection shall verify the seal integrity, confirm the contents against the kit inventory list, verify the within-expiration status of each component, and record the inspector's signature. Broken seals shall be investigated, documented, and resealed promptly. Expired components shall be removed and replaced under pharmacist or physician oversight.

Medication destruction

Medications held for destruction shall be segregated from active storage in a labeled "pending destruction" compartment that is locked and access-controlled. The destruction log shall record the medication, strength, quantity, resident (if applicable), reason for destruction (discontinued, expired, contaminated, recalled), date removed from active storage, date of destruction, method of destruction, witness signature, and staff signature. Destruction shall be performed by a licensed pharmacist or under pharmacist oversight per state regulation, and the chain of custody from removal to destruction shall be maintained as a single record per medication lot.

Operational elements

Access control

Access to medication keys shall be restricted to authorized personnel with documentation of the authorization. A current key roster shall be maintained and updated with any change in staff or assignment. Shift-to-shift key transfer shall be documented. Lost or unaccounted-for keys shall be reported immediately and the affected storage areas re-secured. Personal medication storage areas shall be locked and not accessed by any unauthorized personnel at any time.

External medications and samples

Medications brought in from external prescribers, samples provided by physicians, and resident-owned medications brought into the facility shall receive the same labeling, storage, and accountability treatment as facility-administered medications. Any medication arriving without a complete label shall be held in quarantine until relabeled by the pharmacy vendor, with documentation of the quarantine period in the medication record.

Hotel refrigerator for resident food items

Where the medication refrigerator and the resident food refrigerator are co-located, the facility shall maintain a clear physical separation between pharmaceutical storage and resident food storage. Resident food shall not be stored in the same compartment as any medication. The facility policy shall explicitly address co-location arrangements where present.

Documentation

Documentation generated under this policy shall include: temperature logs for every medication storage area; perpetual controlled substance inventory logs; reconciliation shift-change records; emergency kit inspection logs; medication destruction logs; key access roster and shift transfer logs; quarantine records for medications without complete labels; and the policy and procedure itself. Documentation shall be retained per facility policy (commonly a minimum of one year for operational logs and indefinitely for the policy and any destruction records) and shall be retrievable within surveyor timeframes.

Survey prep checklist

The DON and the consultant pharmacist shall complete a 30-day pre-survey walk-through of every medication storage area covering: complete labeling on every medication, temperature log currency, reconciliation log currency, perpetual inventory reconciliation status, emergency kit inspection currency, destruction log currency, key access roster currency, segregation between pharmaceutical and resident food storage, and the corrective action taken for any identified gap. Walk-through findings and corrective action documentation shall be retained in the survey binder for the trailing 12 months.

References

Primary regulatory authority: 42 CFR §483.45(g)(1)–(2) — Labeling and Storage of Drugs and Biologicals. CMS State Operations Manual, Appendix PP — Guidance to Surveyors for Long Term Care Facilities, F-761. United States Pharmacopeia (USP) chapter <795> and <797> guidance on pharmaceutical compounding and storage where applicable to facility operations. State-specific regulations on controlled substance storage and destruction. Drug Enforcement Administration (DEA) regulations on controlled substance handling where applicable. Facility pharmacy vendor contract and any addenda covering labeling, storage, and destruction responsibility.